Hengrui is considering assembling its own sales force in the US rather than relying on third parties, Mr Zhang said, as the company seeks to overcome the advantage enjoyed by India where “the environmental costs are lower and wages are lower”.
张连山说,恒瑞正考虑在美国组建自己的销售团队,而不是依赖第三方;该公司正寻求抵消“环境成本更低,薪资水平也更低”的印度的药企所享有的优势。
【中国药企热衷对美出口仿制药】相关文章:
最新
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15